|
 CHICAGO (AP) - CVS Caremark Corp. agreed to pay almost $37 million to nearly two dozen states and the federal government to settle claims that the nation's largest pharmacy chain billed Medicaid programs for a more expensive formulation of an antacid, authorities said Tuesday.
The settlement in the case — the first of its kind for a retail pharmacy company — came after a lengthy investigation that began in 2001, when a suburban Chicago pharmacist alerted authorities.
Attorneys said the nation's largest pharmacy chain gave Medicaid patients capsules of Ranitidine (ruh-NIT'-eh-deen), a generic version of the heartburn medication Zantac, instead of even less expensive tablets. Both generic versions of the medication have the same active ingredient.
|